Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,101 to 1,120 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prediction of Sarcopenia Using Multiple Biomarkers of Neuromuscular Junction Degeneration in Chronic Obstructive Pulmonary Disease. | J Pers Med | 2021 | 34575696 | PubTator, text mining | PubMed |
| B Cells and Autoantibodies in AIRE Deficiency. | Biomedicines | 2021 | 34572460 | PubTator, text mining | PubMed |
| Muscle-Related Plectinopathies. | Cells | 2021 | 34572129 | PubTator, text mining | PubMed |
| Intramuscular injection of skeletal muscle derived extracellular matrix mitigates denervation atrophy after sciatic nerve transection. | J Tissue Eng | 2021 | 34567507 | PubTator, text mining | PubMed |
| Elevated N-Linked Glycosylation of IgG V Regions in Myasthenia Gravis Disease Subtypes. | J Immunol | 2021 | 34544801 | PubTator, text mining | PubMed |
| Disease-associated genetic variants in the regulatory regions of human genes: mechanisms of action on transcription and genomic resources for dissecting these mechanisms. | Vavilovskii Zhurnal Genet Selektsii | 2021 | 34541447 | PubTator, text mining | PubMed |
| Fetal akinesia deformation sequence with pontocerebellar hypoplasia, and migration and gyration defects. | Autops Case Rep | 2021 | 34540727 | PubTator, text mining | PubMed |
| Guillain-Barré Syndrome as a Presenting Symptom in Breast Cancer: The Importance of Considering Paraneoplastic Neurologic Syndrome. | Cureus | 2021 | 34532200 | PubTator, text mining | PubMed |
| Therapeutic Plasma Exchange in Myasthenia Gravis: A Systematic Literature Review and Meta-Analysis of Comparative Evidence. | Front Neurol | 2021 | 34531809 | PubTator, text mining | PubMed |
| Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis. | Cell Discov | 2021 | 34521820 | PubTator, text mining | PubMed |
| Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological corrections. | Sci Adv | 2021 | 34516770 | PubTator, text mining | PubMed |
| Evolution of Functional Diversity in the Holozoan Tyrosine Kinome. | Mol Biol Evol | 2021 | 34515793 | PubTator, text mining | PubMed |
| Autoimmune Myasthenia, Primary Adrenal Insufficiency, and Progressive Hypothyroidism Due to Pembrolizumab and Axitinib Combination Regimen. | Cureus | 2021 | 34513503 | PubTator, text mining | PubMed |
| A Rare Presentation of a Rare Disease: Oropharyngeal Dysphagia as The Main Manifestation of Myasthenia Gravis. | Cureus | 2021 | 34513455 | PubTator, text mining | PubMed |
| Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar. | Front Neurol | 2021 | 34512504 | PubTator, text mining | PubMed |
| Imaging immunological processes from blood to brain in amyotrophic lateral sclerosis. | Clin Exp Immunol | 2021 | 34510431 | PubTator, text mining | PubMed |
| Ocular Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Lung Cancer. | Front Immunol | 2021 | 34504488 | PubTator, text mining | PubMed |
| Adapting Disease Prevention Protocols for Human Spaceflight During COVID-19. | Aerosp Med Hum Perform | 2021 | 34503635 | PubTator, text mining | PubMed |
| NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome. | Int J Mol Sci | 2021 | 34502425 | PubTator, text mining | PubMed |
| Laboratory Investigation of Hybrid IgG4 k/λ in MuSK Positive Myasthenia Gravis. | Int J Mol Sci | 2021 | 34502051 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=56